Merck today announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating the safety and efficacy of MK-8527, an investigational once-monthly, oral nucleoside reverse transcriptase translocation inhibitor (NRTTI) for HIV pre-exposure prophylaxis (PrEP). The EXPrESSIVE-11 trial will evaluate the safety and efficacy of MK-8527 among …
Sun Pharmaceutical Industries Limited today announced LEQSELVI (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the U.S. LEQSELVI is indicated for the treatment of adults with severe alopecia areata. “The launch of LEQSELVI in the U.S. …
Merck and Verona Pharma, a biopharmaceutical company focused on respiratory diseases, announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Verona Pharma for $107 per American Depository Share (ADS), each of which represents eight Verona Pharma ordinary …
Q1: What are flow properties of powders, and why are they important? A1: Flow properties refer to the ability of powders to flow smoothly and consistently. They’re crucial in industries like pharmaceuticals, food, and cosmetics, as they affect product quality, processing efficiency, and equipment design. Q2: …
OneSource Specialty Pharma Limited has announced the appointment of Jeffrey Wong as the Chief Business Officer (CBO) of the company effective from July 7, 2025. Wong is a distinguished global commercial executive with over 30 years of experience driving innovation and growth across the biopharmaceutical industry. …
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorisations in the United Kingdom for Vevzuo and Evfraxy, biosimilars of Denosumab. Vevzuo is authorized for the prevention …
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today announced that the European Commission (EC) has granted marketing authorisation in the European Union (EU) for Vevzuo® and Evfraxy® biosimilars of Denosumab. Vevzuo® is authorised for the prevention of bone complications in …
Biocon Biologics’ Malaysian subsidiary, Biocon Sdn. has surpassed the milestone of supplying 100 million cartridges of recombinant human insulin (rh-insulin) to Malaysia’s Ministry of Health (MoH). This achievement reinforces Biocon Biologics’ long-standing commitment to advancing diabetes care and ensuring affordable access to insulin across the country. …
Information Services Group (ISG), a leading global technology research and advisory firm, has identified Indegene as a Leader in its Provider Lens for Life Sciences Digital Services in Commercial Operations – Digital Evolution (Service Providers) Quadrant 2025. Rohan Sinha, Principal Analyst for Healthcare and Life Sciences …
AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation, Directorate General of Health Services, Government of India to import for sale and distribution of Durvalumab Solution for Infusion 120 mg/2.4 ml and 500 mg/10 ml (Brand name: Imfinzi) for an additional …
